Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07335445 · ClinicalTrials.gov registry record · NA
Enhancing Screening Practices for BE
A NA study, sponsored by Rutgers, The State University of New Jersey.
- Not yet
- Registry status
- NA
- Development phase
- 3,000
- Enrollment target
NCT07335445: Clinical Trial NA study, sponsored by Rutgers, The State University of New Jersey.
NCT07335445 is a NA study that has not yet begun recruiting, run by Rutgers, The State University of New Jersey. The registered enrollment target is 3,000 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (114% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07335445, a NA study, has not yet begun recruiting, sponsored by Rutgers, The State University of New Jersey.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 3,000 participants
- Enrollment target
Study Summary
Previous studies have shown that screening for Barrett's esophagus (BE), the main risk factor for esophageal adenocarcinoma, is under-utilized in the primary care setting. In fact less than 35% of eligible patients are screened despite endorsement for screening by the major GI societies in patients with risk factors. The purpose of this study is to examine current screening practices and determine if implementation of screening reminders can optimize screening practices for Barrett's Esophagus within a large, academic based healthcare system in NJ.
Primary Outcome
Percentage increase in BE screening compared to each arm's historical control BE screening rate from the year prior.
Interventions
- OTHER Screening Reminder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 2026-05 |
| Est. Completion | 2029-06 |
| Phase | NA |
What is known before NCT07335445 opens enrollment
NCT07335445 is an interventional study that assigns participants to a tested intervention. Its 3,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (114% higher).
The record links to 0 conditions, and to 1 intervention - of which Screening Reminder is the first listed.
NCT07335445 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07335445 about?
NCT07335445 is a clinical study titled "Enhancing Screening Practices for BE". Previous studies have shown that screening for Barrett's esophagus (BE), the main risk factor for esophageal adenocarcinoma, is under-utilized in the primary care setting. In fact less than 35% of eligible patients are screened despite endorsement for screening by the major GI societies in patients ...
What is the current status of trial NCT07335445?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 3,000 participants. The study started on 2026-05. Estimated completion is 2029-06.
What interventions are being tested in trial NCT07335445?
The interventions under investigation include: Screening Reminder (OTHER).
Who is sponsoring clinical trial NCT07335445?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07335445's enrollment target sits among peer trials
3,000 40th of 2000 higher than 1,959 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004847 · 3,000 participants · Phase 1
Diagnosis of Pheochromocytoma
- NCT00478712 · 3,000 participants
Hirschsprung Disease Genetic Study
- NCT00579566 · 3,000 participants
Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
- NCT00816114 · 3,000 participants
Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia